Harnessing Artificial Intelligence for Global Health Advancement

Abstract

Artificial intelligence (AI) is transforming healthcare, offering the potential to optimize clinical decision-making, improve patient outcomes, and enhance care accessibility. AI-driven tools can analyze vast medical data, enabling early disease detection, accurate diagnoses, and personalized treatment. By addressing challenges such as aging populations, chronic diseases, and workforce shortages, AI can revolutionize global healthcare delivery, particularly in underserved regions. However, successful AI integration requires overcoming barriers like data quality, regulatory frameworks, and ethical considerations. Despite these challenges, AI offers a promising path to more efficient, equitable, and personalized healthcare worldwide.

Share and Cite:

Dhanjal, G. (2025) Harnessing Artificial Intelligence for Global Health Advancement. Journal of Data Analysis and Information Processing, 13, 66-78. doi: 10.4236/jdaip.2025.131004.

1. Introduction

The healthcare landscape is undergoing a transformative shift, with artificial intelligence emerging as a powerful tool that holds immense potential to revolutionize global health delivery [1]-[3]. AI-powered solutions can optimize clinical decision-making, improve patient outcomes, and enhance the accessibility and affordability of high-quality care, particularly in underserved regions [3]. As the world grapples with the challenges of aging populations, the rising burden of chronic diseases, and workforce shortages, integrating AI technology into healthcare systems has become a critical imperative.

2. The Potential of AI In Healthcare

Artificial intelligence, supported by timely and accurate data and evidence, can transform healthcare delivery by enhancing health outcomes, patient safety, and the overall affordability and accessibility of care [3]-[5]. AI-driven systems can analyze complex medical data at an unprecedented scale and precision, enabling early disease detection, accurate diagnoses, and personalized treatment planning [6]. Moreover, AI-powered predictive models can forecast disease outbreaks, optimize hospital operations, and significantly improve patient outcomes [6].

The adoption of AI technology in healthcare has the potential to address the pressing challenges faced by healthcare systems worldwide. AI-powered solutions can bridge the gap between rural and urban health services, democratizing access to high-quality care and addressing disparities in healthcare delivery. Additionally, AI can augment the capabilities of healthcare professionals, mitigating the impact of workforce shortages and burnout, and empowering clinicians to provide more efficient and personalized care.

In the ever-evolving landscape of healthcare, the integration of artificial intelligence has the potential to revolutionize the delivery of care, optimize clinical decision-making, and improve access to healthcare services globally. As the world faces pressing challenges such as aging populations, the growing burden of chronic diseases, and rising healthcare costs, the transformative power of AI holds the promise of addressing these concerns and ushering in a new era of efficient, equitable, and personalized healthcare [1] [3] [4] [6].

The potential applications of artificial intelligence in healthcare extend far beyond diagnostics and treatment. AI’s ability to process and analyze vast amounts of data in real-time also plays a crucial role in advancing research and development. By rapidly identifying patterns and trends in large datasets, AI can accelerate drug discovery, identify potential therapeutic targets, and contribute to the development of precision medicine. This ability to integrate and interpret diverse data sources—from genomic information to clinical trial results—can lead to more effective treatments and faster innovation cycles, ultimately improving patient outcomes [3].

AI technologies can significantly enhance the management of healthcare infrastructure, improving operational efficiency and reducing administrative burdens. Predictive analytics can be used to optimize hospital resources, such as managing patient flow, reducing wait times, and predicting equipment maintenance needs. AI-driven systems can also assist in streamlining administrative tasks, such as medical coding, billing, and appointment scheduling, allowing healthcare professionals to focus more on patient care and less on time-consuming paperwork. These operational improvements can reduce costs and enhance the overall patient experience by ensuring timely and coordinated care delivery [6].

Another promising area for AI is in empowering patients through personalized health management tools. Wearable devices and mobile health applications integrated with AI can provide patients with real-time feedback on their health status, such as monitoring vital signs, medication adherence, and lifestyle behaviors. These AI-driven tools not only help patients manage their health more proactively but also allow healthcare providers to monitor patients remotely and intervene early when necessary. This shift toward preventive care and patient self-management can reduce hospital readmissions, improve chronic disease management, and ultimately contribute to better long-term health outcomes [4].

3. AI Adoption and Regulatory Landscape

While the potential of AI in healthcare is well-recognized, the adoption and implementation of these technologies face several challenges. The successful integration of AI in healthcare requires the availability of standardized, accessible, and high-quality data to train, test, and deploy these systems effectively. This is a significant challenge, as health data across the international community is often fragmented, inconsistent, and difficult to access [7].

The rapid pace of AI innovation has outpaced the development of robust regulatory frameworks, highlighting the need for comprehensive guidelines and oversight to ensure the safe, ethical, and equitable deployment of these technologies [8]. Regulatory bodies, such as the FDA and WHO, have begun to address these concerns, providing guidance on the development, evaluation, and implementation of AI-based healthcare solutions [9].

To bridge the gap between AI research and clinical implementation, robust peer-reviewed clinical studies and randomized controlled trials are essential to generate the necessary evidence for the safety and efficacy of these technologies. Additionally, healthcare systems must address logistical challenges, such as data integration, interoperability, and the seamless integration of AI-powered tools into existing clinical workflows [10].

The integration of artificial intelligence in healthcare holds immense promise, but the path to its successful and widespread adoption requires overcoming significant challenges. Addressing the issues of data accessibility, regulatory frameworks, and practical implementation will be crucial in harnessing the transformative potential of AI to revolutionize global health delivery [4] [10].

4. The Transformative Potential of AI in Healthcare

Artificial intelligence, supported by timely and accurate data, can transform healthcare delivery by enhancing health outcomes, patient safety, and the affordability and accessibility of high-quality care [4]. AI’s exceptional capabilities in pattern recognition, predictive analytics, and decision-making can enable the development of systems that can analyze complex medical data at a scale and precision beyond human capacity [6]. This, in turn, can augment early disease detection, facilitate accurate diagnoses, and aid personalized treatment planning [6].

Moreover, AI-driven predictive models can forecast disease outbreaks, enhance the efficiency of hospital operations, and significantly improve patient outcomes. Additionally, AI has the potential to democratize healthcare by bridging the gap between rural and urban health services and making high-quality care more accessible [6].

Despite the vast potential of AI in healthcare, its full integration faces several challenges. One of the key barriers is the issue of data quality and interoperability. AI-driven healthcare systems rely on large volumes of data sourced from diverse systems and healthcare settings. However, inconsistencies in data formats, incomplete datasets, and varying levels of data quality can hinder the accurate functioning of AI models. To overcome this, the healthcare industry needs to adopt standardized data formats and ensure that electronic health records [EHRs] and other systems are interoperable across platforms. This would not only improve AI model performance but also promote seamless data sharing between healthcare providers, enhancing the overall quality of care [1].

Also, the ethical implications of AI in healthcare cannot be overlooked. Issues such as patient privacy, data security, and algorithmic bias must be addressed to ensure the responsible use of AI technologies.

For instance, AI systems trained on biased datasets may inadvertently perpetuate healthcare disparities, disproportionately affecting underrepresented populations. Ensuring that AI models are developed with diverse, representative datasets is crucial to reducing bias and promoting fairness in healthcare. Moreover, robust data protection measures must be in place to safeguard patient information from breaches and misuse, especially as AI systems become more integrated into healthcare decision-making [5].

Looking ahead, the continued advancement of AI in healthcare will require collaboration between healthcare providers, technology companies, and regulatory bodies. By fostering interdisciplinary partnerships, stakeholders can work together to ensure that AI-driven solutions are safe, effective, and equitable. Furthermore, ongoing research into the ethical and practical challenges associated with AI will be essential for developing policies and frameworks that support the sustainable integration of AI in healthcare. As these efforts progress, the transformative potential of AI to improve patient outcomes, optimize healthcare operations, and make quality care more accessible will become increasingly evident [4].

5. Regulatory Landscape and the Drug Development Process

The integration of AI in healthcare is not without its challenges, including the need for robust regulatory frameworks and the optimization of the drug development process [11]. The FDA has established guidelines for the development and approval of AI-driven healthcare solutions, ensuring that these technologies meet stringent safety and efficacy standards [12]. The drug development process, as outlined by the FDA, involves a multistep approach that includes preclinical research, clinical trials, and a rigorous review process [13]. This process ensures that new drugs are safe, effective, and thoroughly vetted before reaching the market.

AI’s role in healthcare goes far beyond optimizing clinical trials or streamlining data analysis. It introduces both exciting opportunities and complex challenges that touch upon several critical areas, including ethical concerns, patient safety, and regulatory oversight. One significant concern lies in the use of large-scale patient data to train AI models [14]. While these datasets offer the potential to enhance the predictive accuracy and personalized capabilities of AI systems, they also pose substantial risks related to patient privacy and data security. Ensuring that patient information is handled in compliance with legal frameworks like HIPAA [Health Insurance Portability and Accountability Act] is essential, but achieving this on a global scale requires harmonization across international jurisdictions and healthcare systems [15].

The growing reliance on AI in decision-making processes, particularly in clinical settings, raises the issue of algorithmic transparency and bias. AI algorithms are only as good as the data they are trained on, and if these datasets are biased or incomplete, the resulting AI recommendations could lead to unequal healthcare outcomes, particularly for marginalized populations [16]. The potential for AI to inadvertently perpetuate or exacerbate existing disparities in healthcare must be addressed through rigorous testing, monitoring, and the development of unbiased training data. Transparency in how AI systems make decisions is also crucial, as healthcare providers and patients alike must be able to trust that AI-generated insights are grounded in sound logic and evidence [17].

Integrating AI into the healthcare ecosystem will require ongoing collaboration between regulators, industry stakeholders, and medical professionals. As AI technologies evolve, regulatory frameworks will need to adapt in kind, ensuring that innovation is not stifled but that patient safety remains the top priority [3]. Building public trust in these technologies is critical, as the ultimate success of AI in healthcare hinges not only on its technical capabilities but also on how well it is received and accepted by the broader medical community and patients [5].

6. Joining AI with Global Health Advancement

The World Health Organization has recognized the immense potential of AI in healthcare and has highlighted the need to prioritize its integration to enhance global health outcomes. By harnessing the power of AI, healthcare systems around the world can improve population health, enhance the patient experience, and optimize caregiver well-being, all while reducing the rising costs of healthcare [18].

7. Ethical Considerations and Bias in AI

One of the most critical challenges in integrating AI into healthcare is ensuring that ethical concerns are addressed, particularly regarding data usage and algorithmic bias. AI systems rely heavily on large datasets, and if this data is biased or unrepresentative, the outcomes could reinforce existing healthcare disparities [14]. For example, if AI tools are trained primarily on data from specific populations, they may produce inaccurate diagnoses or treatment recommendations for underrepresented groups [16].

The World Health Organization [WHO] has emphasized the need for AI systems to be developed and deployed with fairness and equity in mind, upholding ethical principles such as transparency, accountability, and inclusiveness [18]. Safeguarding patient privacy and ensuring informed consent in data usage are also crucial to maintaining public trust in AI-driven healthcare solutions [19].

8. Governing Frameworks for AI in Healthcare

The adaptation and integration of AI in healthcare require robust governing frameworks to ensure the safety, efficacy, and ethical use of AI-solutions. Regulatory approaches vary across countries, reflecting differences in healthcare priorities, technological infrastructure, and legal systems. A comparative analysis of these frameworks provided insight into how they shape AI adoption in healthcare.

The regulatory process includes rigorous evaluation through clinical trials to ensure that AI technologies function as intended and provide value to both healthcare providers and patients. These regulations play a critical role in ensuring that AI systems are trustworthy, transparent, and aligned with ethical standards [13] [18].

8.1. Comparative Analysis of Regulatory Frameworks

In the United States, the Food and Drug Administration (FDA) regulates AI-based systems under the classification of Software as a Medical Device (SaMD) [20]. This approach emphasizes a comprehensive framework that includes premarket approval, risk-based classification, and ongoing post-market monitoring to ensure safety and reliability [21] [22]. The FDA’s Good Machine Learning Practice (GMLP) guidelines further enhance this process by promoting transparency, reproducibility, and robust validation of AI-driven technologies, ensuring their responsible and effective integration into healthcare [20] [23]-[25].

In the European Union, AI systems in healthcare are regulated by the European Medicines Agency (EMA) and the EU’s Artificial Intelligence Act [26] [27]. The regulatory framework prioritizes patient safety, robust data privacy measures under the General Data Protection Regulation (GDPR), and ethical considerations to ensure fairness and accountability [27]-[29]. AI applications are classified into high-risk, medium-risk, and low-risk categories, with the level of regulatory scrutiny increasing with the potential risk to patient safety [30]-[32]. This structured and patient-centric approach ensures that AI technologies are safely integrated into healthcare systems while maintaining high ethical and privacy standards [30]-[32].

China, India, and Canada each approach AI regulation in healthcare differently, reflecting their unique priorities and challenges. China emphasizes innovation and rapid deployment, which the National Medical Products Administration (NMPA) focuses on clinical efficacy and performance evaluation, while less stringent privacy regulations facilitate faster adoption [33] [34]. In India, AI regulation is still evolving, with current policies aiming to leverage AI for improved healthcare access and affordability. While the Digital Information Security in Healthcare Act (DISHA) provides privacy and data security guidelines, a comprehensive AI-specific framework remains absent [35] [36]. Canada, on the other hand, regulates AI under its Medical Device Regulations through Health Canada, emphasizing premarket reviews and maintaining alignment with the FDA’s rigorous standards to ensure safety and effectiveness [37].

8.2. Impact of Regulatory Approaches on AI Adoption

Regulatory frameworks for AI in Healthcare vary widely, influencing the pace and nature of adoption. Stringent regulatory environments, such as those in the EU and the USA, prioritize patient safety and ethical AI usage through rigorous approval processes, but this often slows innovation [27]-[29]. In contrast, flexible frameworks like China’s enable rapid AI adoption by emphasizing innovation and performance, though they raise concerns about data privacy and the long-term efficacy of deployed systems [33] [34]. Emerging regulatory systems, as seen in India, offer opportunities for experimentation and innovation but risk uneven implementation due to the lack of robust oversight and comprehensive frameworks. Balancing these approaches is crucial to ensuring both safety and progress in AI-driven healthcare [35] [36].

8.3. Global Harmonization and Interoperability

The lack of standardization across regulatory frameworks can hinder global collaboration and the scalability of AI solutions. International organizations like the World Health Organization (WHO) and the International Medical Device Regulators Forum (IMDRF) are working toward developing unified guidelines to promote interoperability and trust in AI-driven healthcare technologies [38] [39].

9. Application of AI in Healthcare

9.1. Diagnostics

Medical Imaging and Radiology: AI algorithms medical images (e.g., X-rays, MRIs, CT scans) to detect abnormalities such as tumors, fractures, or organ damage with precision [40].

Pathology: AI tools identify disease markers in histopathological slides, enabling faster and more accurate diagnoses. Example: AI-driven platforms are assisting pathologists in diagnosing cancers, such as melanoma, through automated image analysis [41].

Early Disease Detection: Predictive models use patient data to identify risk factors and detect diseases like diabetes, cardiovascular conditions, or Alzheimer’s at an early stage. Example: AI tools integrated with wearable devices monitor vital signs and flag early signs of diseases [42].

9.2. Treatment

AI enhances treatment planning and personalization, improving patient outcomes.

Personalized Medicine: AI uses genomic and clinical data to develop tailored treatment plans, reducing trial-and-error approaches. Example: AI-driven precision medicine helps oncologists identify the most effective cancer therapies for individual patients [43] [44].

Surgical Assistance: Robotic systems powered by AI provide precision, reduce human error, and enhance minimally invasive procedures [45].

Medication Management: AI optimizes drug dosages and prevents adverse reactions by analyzing patient data. Example: AI tools assist in managing polypharmacy for patients with multiple chronic conditions [46].

9.3. Operational Efficiency

AI improves the efficiency and cost-effectiveness of healthcare systems.

Hospital Operations: Predictive Analytics optimize patient flow, manage bed availability, and reduce wait times. AI-driven tools help hospitals anticipate demand for ICU beds during flu seasons [47].

Administrative Tasks: Natural Language Processing (NLP) automates documentation, billing, and medical coding, reducing administrative burdens.

Example: AI assistants streamline appointment scheduling and insurance claim processing [47].

Resource Allocation: AI models guide the efficient distribution of resources such as vaccines, medications, and medical supplies. Example: AI tools optimized COVID-19 vaccine distribution by analyzing demographic and geographic data [48].

9.4. Research and Development

Drug Discovery: AI identifies potential drug candidates by analyzing molecular structures and predicting efficacy. Example: AI-powered platforms reduced the time to identify COVID-19 drug candidates [48].

Clinical Trial Optimization: AI selects suitable participants, predicts outcomes, and monitors patient adherence in clinical trials. Example: AI systems have streamlined trial phases for rare disease treatments [49].

9.5. Patient Empowerment and Remote Monitoring

Wearable and Mobile Apps: Devices equipped with AI monitor health metrics (e.g., heart rate, glucose levels) and provide actionable insights. For example, Fitbit and Apple Watch use AI to detect arrhythmias and other cardiac conditions [50].

Telemedicine: AI-powered platforms facilitate virtual consultations, enabling access to healthcare in remote regions. Example: AI chatbots triage symptoms and recommend appropriate care pathways [51].

Behavioral Health Support: AI applications provide mental health support through virtual counseling and self-help programs. For example, AI tools like Woebot offer cognitive behavioral therapy through chat-based interactions [52].

10. Bridging Healthcare Disparities with AI

AI has the potential to address global healthcare disparities by improving access to high-quality care, especially in underserved and rural areas. In resource-limited settings, AI-driven tools such as telemedicine and mobile health platforms can provide remote diagnostic and treatment support, reducing the need for in-person visits and easing the burden on healthcare infrastructure.

For example, USAID is leveraging AI technologies to enhance healthcare delivery in developing countries, helping to optimize care in regions with limited resources [53]. By analyzing large datasets and predicting healthcare trends, AI can help ensure that healthcare is more equitable, providing critical insights that can improve patient outcomes in both high- and low-resource settings.

11. Navigating Workforce Displacement and Skill Gaps

The rise of AI in healthcare also brings concerns about workforce displacement and the need to adapt to new technologies. As AI automates routine tasks such as administrative work and data analysis, healthcare professionals must upskill to collaborate effectively with AI systems. While some jobs may be lost, new roles will emerge that focus on overseeing AI systems, interpreting data, and ensuring ethical AI deployment. It is essential to provide healthcare workers with the training needed to adapt to these changes and avoid over-reliance on AI technologies [18]. By combining human expertise with AI-driven insights, healthcare can be delivered more efficiently and with greater precision, improving both patient care and operational outcomes.

12. Discussion

The integration of artificial intelligence into global healthcare systems offers promising advancements but is met with significant challenges. On the one hand, AI has the potential to optimize clinical decision-making, improve patient outcomes, and address healthcare disparities, particularly in underserved regions. AI can analyze vast amounts of medical data, enabling early disease detection, accurate diagnosis, and personalized treatment, making healthcare more accessible and equitable. AI-driven tools can also streamline hospital operations and reduce administrative burdens, contributing to cost-effective and efficient healthcare delivery.

However, challenges related to data quality, regulatory frameworks, and ethical considerations persist. AI systems require large, standardized datasets, but inconsistencies and accessibility issues often hinder their effectiveness. Ethical concerns, particularly regarding patient privacy, data security, and algorithmic bias, must be addressed to prevent AI from perpetuating healthcare inequalities. Moreover, establishing robust regulatory frameworks is essential for ensuring the safe and effective deployment of AI in clinical settings. Collaborative efforts between healthcare providers, regulatory bodies, and technology developers will be crucial for overcoming these barriers and harnessing AI’s full potential to revolutionize healthcare globally.

13. Conclusion

The integration of artificial intelligence in healthcare holds the promise of transformative change, empowering healthcare providers, patients, and communities to work towards a future of improved health outcomes, increased accessibility, and greater equity in global healthcare delivery.

Conflicts of Interest

The author declares no conflicts of interest regarding the publication of this paper.

References

[1] Gennatas, E. and Chen, J. (2021) Artificial Intelligence in Medicine: Past, Present, and Future. In: Xing, L., Giger, M.L. and Min, J.K., Eds., Artificial Intelligence in Medicine, Elsevier, 1-3.
https://doi.org/10.1016/B978-0-12-821259-2.00026-0
[2] Alami, H., Rivard, L., Lehoux, P., Hoffman, S.J., Cadeddu, S.B.M., Savoldelli, M., et al. (2020) Artificial Intelligence in Health Care: Laying the Foundation for Responsible, Sustainable, and Inclusive Innovation in Low-and Middle-Income Countries. Globalization and Health, 16, Article No. 52.
https://doi.org/10.1186/s12992-020-00584-1
[3] Bajwa, J., Munir, U., Nori, A. and Williams, B. (2021) Artificial Intelligence in Healthcare: Transforming the Practice of Medicine. Future Healthcare Journal, 8, e188-e194.
https://doi.org/10.7861/fhj.2021-0095
[4] Silcox, C., Zimlichmann, E., Huber, K., Rowen, N., Saunders, R., McClellan, M., et al. (2024) The Potential for Artificial Intelligence to Transform Healthcare: Perspectives from International Health Leaders. npj Digital Medicine, 7, Article No. 88.
https://doi.org/10.1038/s41746-024-01097-6
[5] Maleki Varnosfaderani, S. and Forouzanfar, M. (2024) The Role of AI in Hospitals and Clinics: Transforming Healthcare in the 21st Century. Bioengineering, 11, Article 337.
https://doi.org/10.3390/bioengineering11040337
[6] Habchi, Y., Himeur, Y., Kheddar, H., Boukabou, A., Atalla, S., et al. (2023) AI in Thyroid Cancer Diagnosis: Techniques, Trends, and Future Directions. arXiv: 2308.13592.
https://doi.org/10.48550/arXiv.2308.13592
[7] Ahmed, M.I., Spooner, B., Isherwood, J., Lane, M., Orrock, E. and Dennison, A. (2023) A Systematic Review of the Barriers to the Implementation of Artificial Intelligence in Healthcare. Cureus, 15, e46454.
https://doi.org/10.7759/cureus.46454
[8] Mennella, C., Maniscalco, U., De Pietro, G. and Esposito, M. (2024) Ethical and Regulatory Challenges of AI Technologies in Healthcare: A Narrative Review. Heliyon, 10, e26297.
https://doi.org/10.1016/j.heliyon.2024.e26297
[9] Palaniappan, K., Lin, E.Y.T. and Vogel, S. (2024) Global Regulatory Frameworks for the Use of Artificial Intelligence (AI) in the Healthcare Services Sector. Healthcare, 12, Article 562.
https://doi.org/10.3390/healthcare12050562
[10] Kelly, C.J., Karthikesalingam, A., Suleyman, M., Corrado, G. and King, D. (2019) Key Challenges for Delivering Clinical Impact with Artificial Intelligence. BMC Medicine, 17, Article No. 195.
https://doi.org/10.1186/s12916-019-1426-2
[11] Blanco-González, A., Cabezón, A., Seco-González, A., Conde-Torres, D., Antelo-Riveiro, P., Piñeiro, Á., et al. (2023) The Role of AI in Drug Discovery: Challenges, Opportunities, and Strategies. Pharmaceuticals, 16, Article 891.
https://doi.org/10.3390/ph16060891
[12] Benjamens, S., Dhunnoo, P. and Meskó, B. (2020) The State of Artificial Intelligence-Based FDA-Approved Medical Devices and Algorithms: An Online Database. npj Digital Medicine, 3, Article No. 118.
https://doi.org/10.1038/s41746-020-00324-0
[13] FDA (2018) Step 3: Clinical Research.
https://www.fda.gov/patients/drug-development-process/step-3-clinical-research
[14] Yelne, S., Chaudhary, M., Dod, K., Sayyad, A. and Sharma, R. (2023) Harnessing the Power of AI: A Comprehensive Review of Its Impact and Challenges in Nursing Science and Healthcare. Cureus, 15, e49252.
https://doi.org/10.7759/cureus.49252
[15] Li, J. (2023) Security Implications of AI Chatbots in Health Care. Journal of Medical Internet Research, 25, e47551.
https://doi.org/10.2196/47551
[16] Norori, N., Hu, Q., Aellen, F.M., Faraci, F.D. and Tzovara, A. (2021) Addressing Bias in Big Data and AI for Health Care: A Call for Open Science. Patterns, 2, Article 100347.
https://doi.org/10.1016/j.patter.2021.100347
[17] Chen, Y., Clayton, E.W., Novak, L.L., Anders, S. and Malin, B. (2023) Human-Centered Design to Address Biases in Artificial Intelligence. Journal of Medical Internet Research, 25, e43251.
https://doi.org/10.2196/43251
[18] Harnessing Artificial Intelligence for Health.
https://www.who.int/teams/digital-health-and-innovation/harnessing-artificial-intelligence-for-health
[19] Jeyaraman, M., Balaji, S., Jeyaraman, N. and Yadav, S. (2023) Unraveling the Ethical Enigma: Artificial Intelligence in Healthcare. Cureus, 15, e43262.
https://doi.org/10.7759/cureus.43262
[20] Gerke, S., Babic, B., Evgeniou, T. and Cohen, I.G. (2020) The Need for a System View to Regulate Artificial Intelligence/Machine Learning-Based Software as Medical Device. npj Digital Medicine, 3, Article No. 53.
https://doi.org/10.1038/s41746-020-0262-2
[21] Youssef, A., Fronk, D., Grimes, J.N., Cheuy, L. and Larson, D.B. (2024) Beyond the Black Box: Avenues for Transparency in Regulating Radiological AI/ML-Enabled SaMD via the FDA 510(k) Pathway.
https://doi.org/10.1101/2024.07.12.24309602
[22] Healthcare Transformers (n.d.) Healthcare Newsletter for Experts in Health.
https://healthcaretransformers.com/newsletter/
[23] Wu, E., Wu, K., Daneshjou, R., Ouyang, D., Ho, D. and Zou, J. (2021) How Medical AI Devices Are Evaluated: Limitations and Recommendations from an Analysis of FDA Approvals. Nature Medicine, 27, 582-584.
https://pubmed.ncbi.nlm.nih.gov/33820998/
https://doi.org/10.1038/s41591-021-01312-x
[24] Ahmad, M.A., Overman, S., Allen, C., Kumar, V., Teredesai, A. and Eckert, C. (2021) Software as a Medical Device: Regulating AI in Healthcare via Responsible AI. Proceedings of the 27th ACM SIGKDD Conference on Knowledge Discovery & Data Mining, Virtual, 14-18 August 2021, 4023-4024.
https://doi.org/10.1145/3447548.3470823
[25] Good Machine Learning Practice (GMLP): An Essential Guide for Medical Device Manufacturers in 2025.
https://atlan.com/know/data-governance/good-machine-learning-practice-guidelines/
[26] European Medicines Agency (EMA) (n.d.) Artificial Intelligence.
https://www.ema.europa.eu/en/about-us/how-we-work/big-data/artificial-intelligence
[27] Meszaros, J., Minari, J. and Huys, I. (2022) The Future Regulation of Artificial Intelligence Systems in Healthcare Services and Medical Research in the European Union. Frontiers in Genetics, 13, Article 927721.
https://doi.org/10.3389/fgene.2022.927721
[28] Hoofnagle, C.J., van der Sloot, B. and Borgesius, F.Z. (2019) The European Union General Data Protection Regulation: What It Is and What It Means. Information & Communications Technology Law, 28, 65-98.
https://doi.org/10.1080/13600834.2019.1573501
[29] Solaiman, B. and Malik, A. (2024) Regulating Algorithmic Care in the European Union: Evolving Doctor-Patient Models through the Artificial Intelligence Act (AI-Act) and the Liability Directives. Medical Law Review, 33, fwae033.
https://doi.org/10.1093/medlaw/fwae033
[30] Angehrn, Z., Haldna, L., Zandvliet, A.S., Gil Berglund, E., Zeeuw, J., Amzal, B., et al. (2020) Artificial Intelligence and Machine Learning Applied at the Point of Care. Frontiers in Pharmacology, 11, Article 759.
https://doi.org/10.3389/fphar.2020.00759
[31] Kiseleva, A. (2020) Comments on the EU White Paper on AI: A Regulatory Framework for High-Risk Healthcare AI Applications.
https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3627741
[32] Yaeger, K.A., Martini, M., Yaniv, G., Oermann, E.K. and Costa, A.B. (2019) United States Regulatory Approval of Medical Devices and Software Applications Enhanced by Artificial Intelligence. Health Policy and Technology, 8, 192-197.
https://scholars.mssm.edu/en/publications/united-states-regulatory-approval-of-medical-devices-and-software-2
[33] Tang, W., Huang, Y., Zhou, D., Huang, Y., Chen, Y., Ren, S., et al. (2021) Evolving Drug Regulatory Landscape in China: A Clinical Pharmacology Perspective. Clinical and Translational Science, 14, 1222-1230.
https://doi.org/10.1111/cts.12987
[34] Ye, X., Wang, Q. and Wang, H. (2019) New Era of Drug Innovation in China. Acta Pharmaceutica Sinica B, 9, 1084-1085.
https://doi.org/10.1016/j.apsb.2019.06.002
[35] Ganapathy, K. (2021) Artificial Intelligence and Healthcare Regulatory and Legal Concerns. Telehealth and Medicine Today, 6, Article 252.
https://doi.org/10.30953/tmt.v6.252
[36] Saini, A.K., Yadav, R., Shekhawat, S.S., Vats, P., Yadav, S.L., Singh, A.P., et al. (2023) AI in Healthcare: Navigating the Ethical, Legal, and Social Implications for Improved Patient Outcomes. 2023 International Conference on Data Science and Network Security (ICDSNS), Tiptur, 28-29 July 2023, 1-8.
https://doi.org/10.1109/icdsns58469.2023.10245763
[37] Silva, M., Flood, C., Goldenberg, A. and Singh, D. (2022) Regulating the Safety of Health-Related Artificial Intelligence. Healthcare Policy/Politiques de Santé, 17, 63-77.
https://doi.org/10.12927/hcpol.2022.26824
[38] Pearson, R. and Diamond, M. (2025) Artificial Intelligence/Machine Learning-Enabled. International Medical Device Regulators Forum.
https://www.imdrf.org/working-groups/artificial-intelligencemachine-learning-enabled
[39] Global Initiative on AI for Health.
https://www.who.int/initiatives/global-initiative-on-ai-for-health
[40] Pinto-Coelho, L. (2023) How Artificial Intelligence Is Shaping Medical Imaging Technology: A Survey of Innovations and Applications. Bioengineering, 10, Article 1435.
https://doi.org/10.3390/bioengineering10121435
[41] Shafi, S. and Parwani, A.V. (2023) Artificial Intelligence in Diagnostic Pathology. Diagnostic Pathology, 18, Article No. 109.
https://doi.org/10.1186/s13000-023-01375-z
[42] Oluwagbade, E. and Covenant, L. (2024) How AI Can Help Healthcare Providers Identify High-Risk Patients for Early Intervention.
https://www.researchgate.net/publication/386177140_How_AI_Can_Help_Healthcare_Providers_Identify_High-Risk_Patients_for_Early_Intervention
[43] Schork, N.J. (2019) Artificial Intelligence and Personalized Medicine. In: Von Hoff, D. and Han, H., Eds., Cancer Treatment and Research, Springer International Publishing, 265-283.
https://doi.org/10.1007/978-3-030-16391-4_11
[44] Johnson, K.B., Wei, W., Weeraratne, D., Frisse, M.E., Misulis, K., Rhee, K., et al. (2020) Precision Medicine, AI, and the Future of Personalized Health Care. Clinical and Translational Science, 14, 86-93.
https://doi.org/10.1111/cts.12884
[45] Liu, Y., Wu, X., Sang, Y., Zhao, C., Wang, Y., Shi, B., et al. (2024) Evolution of Surgical Robot Systems Enhanced by Artificial Intelligence: A Review. Advanced Intelligent Systems, 6, Article ID: 2300268.
https://doi.org/10.1002/aisy.202300268
[46] Alsanosi, S.M. and Padmanabhan, S. (2024) Potential Applications of Artificial Intelligence (AI) in Managing Polypharmacy in Saudi Arabia: A Narrative Review. Healthcare, 12, Article 788.
https://doi.org/10.3390/healthcare12070788
[47] Iseal, S., Caleb, A. and William, B. (2023) Improving Hospital Management Systems with Intelligent Tools.
https://www.researchgate.net/publication/386479369_Improving_Hospital_Management_Systems_with_Intelligent_Tools
[48] Chang, Z., Zhan, Z., Zhao, Z., You, Z., Liu, Y., Yan, Z., et al. (2021) Application of Artificial Intelligence in COVID-19 Medical Area: A Systematic Review. Journal of Thoracic Disease, 13, 7034-7053.
https://doi.org/10.21037/jtd-21-747
[49] Chopra, H., Annu, Shin, D.K., Munjal, K., Priyanka, Dhama, K., et al. (2023) Revolutionizing Clinical Trials: The Role of Ai in Accelerating Medical Breakthroughs. International Journal of Surgery, 109, 4211-4220.
https://doi.org/10.1097/js9.0000000000000705
[50] Bhaltadak, V., Ghewade, B. and Yelne, S. (2024) A Comprehensive Review on Advancements in Wearable Technologies: Revolutionizing Cardiovascular Medicine. Cureus, 16, e61312.
https://doi.org/10.7759/cureus.61312
[51] Abbasi, N. (2024) Artificial Intelligence in Remote Monitoring and Telemedicine. Journal of Artificial Intelligence General Science, 1, 258-272.
https://doi.org/10.60087/jaigs.v1i1.202
[52] Woebot Health.
https://woebothealth.com/
[53] U.S. Agency for International Development (n.d.) Artificial Intelligence in Global Health: Defining a Collective Path Forward.
https://2017-2020.usaid.gov/cii/ai-in-global-health

Copyright © 2025 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.